44 results on '"Jang, Yangsoo"'
Search Results
2. Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings
3. Relation of Preprocedural Hemoglobin Level to Outcomes After Percutaneous Coronary Intervention
4. Effect of Perioperative Antiplatelet Therapy on Outcomes in Patients With Drug-Eluting Stents Undergoing Elective Noncardiac Surgery
5. Patient-Centered Decision-Making of Revascularization Strategy for Left Main or Multivessel Coronary Artery Disease
6. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation
7. Impact of National Health Checkup Service on Hard Atherosclerotic Cardiovascular Disease Events and All-Cause Mortality in the General Population
8. Usefulness of Intraprocedural Coronary Computed Tomographic Angiography During Intervention for Chronic Total Coronary Occlusion
9. Comparison of Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion Using Everolimus- Versus Sirolimus- Versus Paclitaxel-Eluting Stents (from the Korean National Registry of Chronic Total Occlusion Intervention)
10. Optical Coherence Tomographic Evaluation of the Effect of Cigarette Smoking on Vascular Healing After Sirolimus-Eluting Stent Implantation
11. Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
12. Usefulness of Intravascular Ultrasound Guidance in Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents for Chronic Total Occlusions (from the Multicenter Korean-Chronic Total Occlusion Registry)
13. Efficacy of Early Intensive Rosuvastatin Therapy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (ROSEMARY Study)
14. Mechanisms of Postintervention and Nine-Month Luminal Enlargement After Treatment of Drug-Eluting In-Stent Restenosis With a Drug-Eluting Balloon
15. Usefulness of Intravascular Ultrasound to Predict Outcomes in Short-Length Lesions Treated With Drug-Eluting Stents
16. Comparison of Early Strut Coverage Between Zotarolimus- and Everolimus-Eluting Stents Using Optical Coherence Tomography
17. Outcomes According to Presentation With Versus Without Cardiogenic Shock in Patients With Left Main Coronary Artery Stenosis and Acute Myocardial Infarction
18. Efficacy of Drug-Eluting Stents for Treating In-Stent Restenosis of Drug-Eluting Stents (from the Korean DES ISR Multicenter Registry Study [KISS])
19. Different Clinical Outcome of Paravalvular Leakage After Aortic or Mitral Valve Replacement
20. Clinical and Echocardiographic Predictors of Outcomes in Patients With Apical Hypertrophic Cardiomyopathy
21. Relation of Homocysteinemia to Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention
22. Neointimal Coverage on Drug-Eluting Stent Struts Crossing Side-Branch Vessels Using Optical Coherence Tomography
23. Different Vascular Healing Patterns With Various Drug-Eluting Stents in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Optical Coherence Tomographic Findings
24. Relation of Genetic Polymorphisms in the Cytochrome P450 Gene With Clopidogrel Resistance After Drug-Eluting Stent Implantation in Koreans
25. Intravascular Ultrasound Evaluation of Optimal Drug-Eluting Stent Expansion After Poststent Balloon Dilation Using a Noncompliant Balloon Versus a Semicompliant Balloon (from the Poststent Optimal Stent Expansion Trial [POET])
26. Effects of Hemoglobin Concentration and Creatinine Clearance in Pro-B-Type Natriuretic Peptide-Based Left Ventricular Filling Pressure Prediction in Patients With Preserved Left Ventricular Systolic Function
27. Incremental Value of Measuring the Time Difference Between Onset of Mitral Inflow and Onset of Early Diastolic Mitral Annulus Velocity for the Evaluation of Left Ventricular Diastolic Pressures in Patients With Normal Systolic Function and an Indeterminate E/Eā²
28. Comparison of Long-Term Outcome After Mitral Valve Replacement or Repeated Balloon Mitral Valvotomy in Patients With Restenosis After Previous Balloon Valvotomy
29. Comparison of Effects of Drug-Eluting Stents Versus Bare Metal Stents on Plasma C-Reactive Protein Levels
30. Is the left atrial v wave the determinant of peak pulmonary artery pressure in patients with pure mitral stenosis?
31. Usefulness of cilostazol versus ticlopidine in coronary artery stenting
32. Neointimal Response to Second Generation Drug-eluting Stents in Diabetic Patients with De Novo Coronary Lesions; Intravascular Ultrasound Study
33. AS-168 Unprotected Left Main Stenting with Everolimus-Eluting Stent: PRECOMBAT-2 Study
34. AS-073 Effect of Valsartan on Suppression of Neointimal Hyperplasia after Drug-Eluting Stents and on Regression of Native Plaque Volume: The Val-SUPPRES Randomized Controlled Trial
35. AS-149: Angiographic Outcomes of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents for Native Coronary Arteries: Angiographic Study of the ZEST Trial
36. AS-152: Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization in a Real-World Setting
37. AS-153: Comparison of Zotarolimus-Eluting Stents Versus Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents for the Treatment of Very Long Lesions: Subgroup Study of the ZEST Trial
38. AS-157: Comparison of Zotarolimus-Eluting Stents with Sirolimus-Eluting and Paclitaxel-Eluting Stents for Patients with Diabetes Mellitus in the ZEST Trial: A Subanalysis of a Randomized Trial
39. AS-22: Different Findings of Neointimal Coverage and Stent Malapposition in Drug-Eluting Stents Using Optical Coherence Tomography in ST-Elevation Myocardial Infarction
40. AS-138: Are There Differences in Clinical Outcomes after Target Lesion Revascularization for Restenosis According to the Type of Restenosed Drug-Eluting Stent? Comparisons between Sirolimus- versus Paclitaxel-Eluting Stent Restenosis
41. AS-25: Rate of Neointimal Coverage Is Different According to Initial Clinical Presentation and Types of Drug-Eluting Stents: Optical Coherence Tomography Findings
42. Magnitude of left atrial V wave is the determinant of exercise capacity in patients with mitral stenosis
43. Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease
44. Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.